Prediction of dyslipidemia using gene mutations, family history of diseases and anthropometric indicators in children and adolescents: The CASPIAN-III study

• Published in: Computational and structural biotechnology journal Vol. 16; pp. 121 - 130
• Main Authors: Marateb, Hamid R., Mohebian, Mohammad Reza, Javanmard, Shaghayegh Haghjooy, Tavallaei, Amir Ali, Tajadini, Mohammad Hasan, Heidari-Beni, Motahar, Mañanas, Miguel Angel, Motlagh, Mohammad Esmaeil, Heshmat, Ramin, Mansourian, Marjan, Kelishadi, Roya
• Format: Journal Article Publication
• Language: English
• Published: Netherlands Elsevier B.V 01.01.2018; Elsevier; Research Network of Computational and Structural Biotechnology
• Subjects: adolescents; adulthood; algorithms; Automàtica i control; Bioengineering; Bioenginyeria; biotechnology; children; Ciències de la salut; Computer-assisted diagnosis; coronary disease; data collection; decision support systems; Deep learning; diagnosis; Dyslipidemia; Dyslipidemia Genomics; Dyslipidemias; genes; Genomics; Genètica mèdica; Health promotion; hyperlipidemia; Informàtica; Intel·ligència artificial; Iran; lifestyle; lipid composition; lipoproteins; Machine learning; males; Medicina; neural networks; prediction; protein metabolism; regression analysis; risk factors; screening; single nucleotide polymorphism; Àrees temàtiques de la UPC; Iran; Deep learning; Computer-assisted diagnosis; Health promotion; Genomics; Dyslipidemia; Machine learning
• ISSN: 2001-0370; 2001-0370
• DOI: 10.1016/j.csbj.2018.02.009

Dyslipidemia, the disorder of lipoprotein metabolism resulting in high lipid profile, is an important modifiable risk factor for coronary heart diseases. It is associated with more than four million worldwide deaths per year. Half of the children with dyslipidemia have hyperlipidemia during adulthood, and its prediction and screening are thus critical. We designed a new dyslipidemia diagnosis system. The sample size of 725 subjects (age 14.66 ± 2.61 years; 48% male; dyslipidemia prevalence of 42%) was selected by multistage random cluster sampling in Iran. Single nucleotide polymorphisms (rs1801177, rs708272, rs320, rs328, rs2066718, rs2230808, rs5880, rs5128, rs2893157, rs662799, and Apolipoprotein-E2/E3/E4), and anthropometric, life-style attributes, and family history of diseases were analyzed. A framework for classifying mixed-type data in imbalanced datasets was proposed. It included internal feature mapping and selection, re-sampling, optimized group method of data handling using convex and stochastic optimizations, a new cost function for imbalanced data and an internal validation. Its performance was assessed using hold-out and 4-foldcross-validation. Four other classifiers namely as supported vector machines, decision tree, and multilayer perceptron neural network and multiple logistic regression were also used. The average sensitivity, specificity, precision and accuracy of the proposed system were 93%, 94%, 94% and 92%, respectively in cross validation. It significantly outperformed the other classifiers and also showed excellent agreement and high correlation with the gold standard. A non-invasive economical version of the algorithm was also implemented suitable for low- and middle-income countries. It is thus a promising new tool for the prediction of dyslipidemia. •Dyslipidemia is an important modifiable risk factor for coronary heart diseases.•Its prediction and screening are critical in children and adolescents.•We designed a new dyslipidemia diagnosis system as a new classification framework.•Gene mutations, genetic, and anthropometric attributes were analyzed.•The proposed framework showed excellent agreement with the gold standard.